Astrazeneca AZN
NYSE AZN
$156.91 -0.77 (-0.49%)
At close: Oct 2, 2026 · 4:00 PM EDT

Astrazeneca (AZN) Gains from Investment Securities (2010 - 2018)

Updated

Astrazeneca (AZN) recorded Gains from Investment Securities of $3 million in Q3 2018, down 92.1% from the prior quarter.

Analysis

Astrazeneca (AZN) Gains from Investment Securities (2010 - 2018) Analysis & Trends

On a TTM basis, Astrazeneca's Gains from Investment Securities came in at $121 million as of Sep 30, 2018.

  • The Q3 2018 figure is the lowest quarterly Gains from Investment Securities since Q3 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Vertex Pharmaceuticals 127.87 Bn 99.88 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 3.00 Mn
Jun 30, 2018 38.00 Mn
Mar 31, 2018 118.00 Mn
Sep 30, 2011 -38.00 Mn
Mar 31, 2011 41.00 Mn
Sep 30, 2010 42.00 Mn
Mar 31, 2010 -156.00 Mn
API Access

Astrazeneca Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=AZN&period=max&api_key=YOUR_API_KEY